Novavax
COVID-19: Health Min. offers non-mRNA vaccine, alt. for Pfizer, Moderna
It has obtained supplies of Nuvaxovid from the Novavax company. It is a vaccine that protects against serious complications of the pandemic without being based on mRNA.
European Medicines Agency recommends Novavax add warning to their COVID-19 vaccine
Novavax could have vaccine for COVID-19 Omicron variant by January
Novavax developing vaccine that targets new COVID-19 variant
Novavax COVID-19 vaccine more than 90% effective in US trial
Novavax's protein-based COVID-19 vaccine candidate was more than 93% effective against the predominant variants of COVID-19 that have been of concern among scientists and public health officials.